238 related articles for article (PubMed ID: 9581595)
1. Prostate cancer in the serum prostate-specific antigen era.
Humphrey PA
Mayo Clin Proc; 1998 May; 73(5):489-90. PubMed ID: 9581595
[No Abstract] [Full Text] [Related]
2. Prostate cancer screening; is this a teachable moment?
Brawley OW
J Natl Cancer Inst; 2009 Oct; 101(19):1295-7. PubMed ID: 19720970
[No Abstract] [Full Text] [Related]
3. Efficacy vs effectiveness in prostate-specific antigen screening.
Albertsen PC
J Natl Cancer Inst; 2010 Mar; 102(5):288-9. PubMed ID: 20142583
[No Abstract] [Full Text] [Related]
4. Screening for prostate cancer - will we ever know?
Adolfsson J
Acta Oncol; 2010 Apr; 49(3):275-7. PubMed ID: 20397764
[No Abstract] [Full Text] [Related]
5. Prostate specific antigen and screening for early prostate cancer.
Davidson P
N Z Med J; 2001 Apr; 114(1129):150. PubMed ID: 11400919
[No Abstract] [Full Text] [Related]
6. Why are a high overdiagnosis probability and a long lead time for prostate cancer screening so important?
Barry MJ; Mulley AJ
J Natl Cancer Inst; 2009 Mar; 101(6):362-3. PubMed ID: 19276451
[No Abstract] [Full Text] [Related]
7. Re: Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005.
Belpomme D; Irigaray P
J Natl Cancer Inst; 2010 Apr; 102(7):506-7. PubMed ID: 20190186
[No Abstract] [Full Text] [Related]
8. Celebrating the death of PSA screening?
Gomella LG
Can J Urol; 2011 Dec; 18(6):5987. PubMed ID: 22166323
[No Abstract] [Full Text] [Related]
9. Screening for prostate cancer: recommendations and rationale.
Berg AO;
Am J Nurs; 2003 Mar; 103(3):107-10; discussion 111. PubMed ID: 12626949
[No Abstract] [Full Text] [Related]
10. Prostate-specific antigen and prostate cancer prognosis.
Church TR
J Natl Cancer Inst; 2006 Nov; 98(21):1509-10. PubMed ID: 17077347
[No Abstract] [Full Text] [Related]
11. Re: Prostate-specific antigen: a misused and maligned prostate cancer biomarker.
Hamilton RJ; Platz EA; Freedland SJ
J Natl Cancer Inst; 2009 Apr; 101(8):611-2. PubMed ID: 19351913
[No Abstract] [Full Text] [Related]
12. Prostate cancer options expand beyond the PSA.
Clin Resour Manag; 2002 May; 3(5):65-8. PubMed ID: 12048767
[No Abstract] [Full Text] [Related]
13. Early detection of prostate cancer. Role of prostate-specific antigen.
Prabhakaran VM
Can Fam Physician; 1996 Apr; 42():709-12. PubMed ID: 8653039
[TBL] [Abstract][Full Text] [Related]
14. The PSA era is not over for prostate cancer.
Catalona WJ; Loeb S
Eur Urol; 2005 Oct; 48(4):541-5. PubMed ID: 16139417
[No Abstract] [Full Text] [Related]
15. Clinical practice. Screening for prostate cancer.
Hoffman RM
N Engl J Med; 2011 Nov; 365(21):2013-9. PubMed ID: 22029754
[No Abstract] [Full Text] [Related]
16. What is the value of screening for prostate cancer in the US?
Albertsen PC
Nat Clin Pract Oncol; 2005 Nov; 2(11):536-7. PubMed ID: 16270077
[No Abstract] [Full Text] [Related]
17. Re: Is a screening interval of every 4 years for prostate cancer acceptable?
Roobol MJ; Schröder FH
J Natl Cancer Inst; 2008 Feb; 100(3):222; author reply 223-4. PubMed ID: 18230797
[No Abstract] [Full Text] [Related]
18. Prostate cancer mortality rates compared to urologist population densities and prostate-specific antigen screening levels on a state-by-state basis in the United States of America.
Colli JL; Amling CL
Prostate Cancer Prostatic Dis; 2008; 11(3):247-51. PubMed ID: 18268527
[TBL] [Abstract][Full Text] [Related]
19. Regular PSA screens undervalued, underutilized in prostate cancer detection.
Healthc Demand Dis Manag; 2000 May; 6(5):70-2, 65. PubMed ID: 11383016
[TBL] [Abstract][Full Text] [Related]
20. What happens to older men after a screening test for prostate cancer?
BMJ; 2013 Apr; 346():f2421. PubMed ID: 23596225
[No Abstract] [Full Text] [Related]
[Next] [New Search]
